Check out the latest features and columns!

Pharmaceutical Executive January 2023

January's Executive Profile features Natalie Bickford, chief people officer at Sanofi

Enabling Authenticity

Pharm Exec's 18th Annual Pipeline Report focuses on spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics

Testing the Limits

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences stakeholders

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Click for more information and to submit a nomination

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards

Articles

Amgen Lays Off 300 Employees, "Mainly Its Commercial Team"

Sysnav Healthcare and Roche enter a partnership to facilitate development of industry standard outcome measurements in diseases associated with movement impairments, as well as designing the next generation of wearable technology based on Sysnav's technology.

Sysnav Healthcare Announces a Multi-Year Collaboration with Roche

 and can be reached at fpollaro@mjhlifesciences.com.

What’s changing in post-pandemic HCP access? Veeva’s vice president of global business consulting unveils the latest data.

Post-Pandemic HCP Access: Q&A with Dan Rizzo, Vice President of Veeva Global Business Consulting

A Q&A with Bridget Seay, epocrates’ executive director of customer experience & commercial consulting.

Q&A with Bridget Seay, epocrates’ Executive Director of Customer Experience & Commercial Consulting

Jill Wechsler is Pharm Exec's Washington Corespondent

Agency panel backs the use of a common bivalent shot for all patients.

FDA Seeks to Simplify COVID Vaccination Program

Cora Meese is the EVP, director of client services, for Entrée Health.

As pharmaceutical market access teams head into 2023, these ten trends detail why evolved preparation, thought, and engagement will be needed to meet post-pandemic marketplace expectations. 

10 Market Access Trends to Watch for in 2023

"AH-ha!™ It's Acne Hormones" features  people affected by acne and highlights "AH-ha" moments to "pop" common acne myths and misconceptions.

Featured Content

Pharmaceutical Executive January 2023

Enabling Authenticity

Testing the Limits

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

Pharmaceutical Executive 2023 Emerging Pharma Leaders Awards